Henry Schein tops Q3 expectations, raises full-year guidance

Published 04/11/2025, 12:10
 Henry Schein tops Q3 expectations, raises full-year guidance

Investing.com - Henry Schein (NASDAQ:HSIC) on Tuesday reported stronger-than-expected third quarter results on Monday, as the healthcare solutions provider saw accelerating sales growth across all segments and raised its full-year outlook.

The world’s largest provider of healthcare solutions to office-based dental and medical practitioners posted adjusted earnings of $1.38 per share for the third quarter, exceeding analyst expectations of $1.28. Revenue rose 5.2% YoY to $3.34 billion, surpassing the consensus estimate of $3.28 billion.

"We are pleased with our financial results for the third quarter, with sales growth accelerating in each of our reportable segments including solid market share gains in our distribution businesses as we are once again focused on driving growth now that the cyber incident is fully behind us," said Stanley M. Bergman, Chairman and CEO of Henry Schein .

The company’s global dental distribution merchandise sales increased 4.6% compared to the same period last year, while medical distribution sales grew 4.7%. Global specialty products and technology sales showed strong performance, rising 5.9% and 9.7% respectively.

Following the strong quarterly performance, Henry Schein raised its 2025 adjusted EPS guidance to $4.88-$4.96 from its previous range of $4.80-$4.94, above the analyst consensus of $4.82. The company also increased its total sales growth forecast to 3-4% over 2024, up from its earlier projection of 2-4%.

Additionally, Henry Schein announced value creation initiatives expected to deliver over $200 million in operating income improvements over the next few years. The company also reached an agreement allowing KKR to increase its stock ownership in HSIC up to 19.9%.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.